PWAM
ATRS

Park West Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Park West Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-500,000
Closed -$1.75M – 66
2014
Q1 		$1.75M Buy
+500,000
New +$2.22M 0.2% 61

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Park West Asset Management's ATRS Position: Q2 2014 in Review

Park West Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2014, closing a stake of 500,000 shares — an estimated $1.75M sold.

Park West Asset Management first reported a position in ATRS in Q1 2014 and held it in 1 quarter. The position peaked at $1.75M in Q1 2014. 85 funds tracked by Wall St. Rank hold ATRS as of Q2 2014.

  • Park West Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2014 after selling out during the quarter.
  • Park West Asset Management sold 500,000 Antares Pharma, Inc. shares in Q2 2014, an estimated $1.75M.
  • Park West Asset Management first reported a position in Antares Pharma, Inc. in Q1 2014 and held it in 1 quarter.
  • Park West Asset Management's Antares Pharma, Inc. position peaked at $1.75M in Q1 2014.
  • 85 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2014.

Based on Park West Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.